LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients.

    Einvik, Gunnar / Dammen, Toril / Ghanima, Waleed / Heir, Trond / Stavem, Knut

    International journal of environmental research and public health

    2021  Volume 18, Issue 4

    Abstract: ... post-traumatic stress disorder (PTSD) in a cohort of hospitalized and non-hospitalized patients about 1.5-6 months after ... hospitalized and 938 non-hospitalized subjects received invitation. The prevalence of symptom-defined PTSD was ... Coronavirus-2 (SARS-CoV-2) until 1 June 2020, comprising both hospitalized and non-hospitalized subjects ...

    Abstract This population-based study assessed the prevalence and determinants of symptom-defined post-traumatic stress disorder (PTSD) in a cohort of hospitalized and non-hospitalized patients about 1.5-6 months after their COVID-19 onset. The data were acquired from two mixed postal/web surveys in June-September 2020 from patients all aged ≥18 years with a positive polymerase chain reaction for severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) until 1 June 2020, comprising both hospitalized and non-hospitalized subjects. The catchment areas of the two included hospitals covers about 17% of the population of Norway. In total, 211 hospitalized and 938 non-hospitalized subjects received invitation. The prevalence of symptom-defined PTSD was assessed using the PTSD checklist for DSM-5 (PCL-5). Determinants of symptom-defined PTSD and PTSD symptoms were analyzed using multivariable logistic and linear regression analysis. In total, 583 (51%) subjects responded at median 116 (range 41-200) days after COVID-19 onset. The prevalence of symptom-defined PTSD was 9.5% in hospitalized and 7.0% in non-hospitalized subjects (
    MeSH term(s) Adult ; Aged ; COVID-19/psychology ; Female ; Humans ; Male ; Middle Aged ; Norway/epidemiology ; Prevalence ; Risk Factors ; Stress Disorders, Post-Traumatic/epidemiology
    Language English
    Publishing date 2021-02-20
    Publishing country Switzerland
    Document type Journal Article
    ISSN 1660-4601
    ISSN (online) 1660-4601
    DOI 10.3390/ijerph18042079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Prevalence and Risk Factors for Post-Traumatic Stress in Hospitalized and Non-Hospitalized COVID-19 Patients

    Gunnar Einvik / Toril Dammen / Waleed Ghanima / Trond Heir / Knut Stavem

    International Journal of Environmental Research and Public Health, Vol 18, Iss 2079, p

    2021  Volume 2079

    Abstract: ... post-traumatic stress disorder (PTSD) in a cohort of hospitalized and non-hospitalized patients about 1.5–6 months after ... of Norway, and dyspnea during COVID-19 were risk factors for persistent PTSD symptoms. In non-hospitalized ... hospitalized and 938 non-hospitalized subjects received invitation. The prevalence of symptom-defined PTSD was ...

    Abstract This population-based study assessed the prevalence and determinants of symptom-defined post-traumatic stress disorder (PTSD) in a cohort of hospitalized and non-hospitalized patients about 1.5–6 months after their COVID-19 onset . The data were acquired from two mixed postal/web surveys in June–September 2020 from patients all aged ≥18 years with a positive polymerase chain reaction for severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) until 1 June 2020, comprising both hospitalized and non-hospitalized subjects. The catchment areas of the two included hospitals covers about 17% of the population of Norway. In total, 211 hospitalized and 938 non-hospitalized subjects received invitation. The prevalence of symptom-defined PTSD was assessed using the PTSD checklist for DSM-5 (PCL-5). Determinants of symptom-defined PTSD and PTSD symptoms were analyzed using multivariable logistic and linear regression analysis. In total, 583 (51%) subjects responded at median 116 (range 41–200) days after COVID-19 onset. The prevalence of symptom-defined PTSD was 9.5% in hospitalized and 7.0% in non-hospitalized subjects ( p = 0.80). Female sex, born outside of Norway, and dyspnea during COVID-19 were risk factors for persistent PTSD symptoms. In non-hospitalized subjects, previous depression and COVID-19 symptom load were also associated with persistent PTSD symptoms. In conclusion, COVID-19 symptom load, but not hospitalization, was associated with symptom-defined PTSD and PTSD symptom severity.
    Keywords post-traumatic stress disorder ; COVID-19 ; cohort study ; outpatients ; hospitalized ; intensive care unit ; Medicine ; R
    Subject code 150
    Language English
    Publishing date 2021-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.

    Luo, De / Mei, Bingjie / Wang, Piao / Li, Xujia / Chen, Xinpei / Wei, Gang / Kuang, Fei / Li, Bo / Su, Song

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

    2023  Volume 30, Issue 3, Page(s) 328–335

    Abstract: ... symptom prevalence and risk ratios comparing COVID-19 patients with non-COVID-19 individuals ... patients had a significantly higher prevalence of most persistent symptoms compared with non-COVID-19 ... a thorough review of the prevalence and risk factors for persistent symptoms following COVID-19. The findings ...

    Abstract Background: Long-term physical and mental persistent symptoms after COVID-19 represent a growing global public health concern. However, there remains a substantial knowledge gap regarding their prevalence and risk factors.
    Objectives: To estimate the prevalence and risk factors for persistent symptoms after COVID-19.
    Methods of data synthesis: We used a random-effects model to pool persistent symptom prevalence and risk ratios comparing COVID-19 patients with non-COVID-19 individuals.
    Data sources: Electronic databases were searched for studies published from December 2019 to January 2023.
    Study eligibility criteria: Eligible studies that reported the prevalence and risk factors for persistent symptoms after COVID-19 were included.
    Participants: Patients who recovered from COVID-19.
    Assessment of risk of bias: The Joanna Briggs Institute critical appraisal tool was used to assess the risk of bias in prevalence studies, whereas the risk of bias in cohort studies was evaluated with the Newcastle-Ottawa Scale.
    Results: After screening 4359 studies, a total of 211 eligible studies were included, covering a population of 13 368 074 individuals. Fatigue, dyspnoea, post-traumatic stress disorder, anxiety, and depression were the most frequently reported persistent symptoms after COVID-19. Subgroup analyses revealed that individuals with more severe illness in the acute phase or from Europe exhibited a higher prevalence of certain symptoms, whereas children demonstrated a lower prevalence. Furthermore, COVID-19 patients had a significantly higher prevalence of most persistent symptoms compared with non-COVID-19 individuals. Factors frequently associated with a higher prevalence of persistent symptoms included female gender, advanced age, severe illness during the acute phase of COVID-19, multiple comorbidities, an extended duration of hospital stay, and a high body mass index.
    Conclusion: This meta-analysis provides a thorough review of the prevalence and risk factors for persistent symptoms following COVID-19. The findings underscore the importance of long-term monitoring and support for individuals recovering from COVID-19.
    MeSH term(s) Child ; Humans ; Female ; COVID-19/complications ; COVID-19/epidemiology ; Prevalence ; Bias ; Risk Factors ; Cohort Studies
    Language English
    Publishing date 2023-10-20
    Publishing country England
    Document type Meta-Analysis ; Systematic Review ; Journal Article ; Review
    ZDB-ID 1328418-6
    ISSN 1469-0691 ; 1470-9465 ; 1198-743X
    ISSN (online) 1469-0691
    ISSN 1470-9465 ; 1198-743X
    DOI 10.1016/j.cmi.2023.10.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Prevalence and risk factors of psychological symptoms and quality of life in COVID-19 survivors: A cross-sectional study of three different populations.

    Emıroglu, Canan / Gorpelıoglu, Süleyman / Ozagar, Serap Demirelli / Demır, Pervin / Aypak, Cenk

    International journal of nursing practice

    2023  Volume 30, Issue 3, Page(s) e13202

    Abstract: ... on psychological health in non-severe cases are limited. We aimed to evaluate the prevalence and associated risk factors ... at a rate of 10.9%, post-traumatic stress disorder symptoms at a rate of 28.6% and ... Aim: Studies of the effects of COVID-19, especially post-acute COVID-19 syndrome ...

    Abstract Aim: Studies of the effects of COVID-19, especially post-acute COVID-19 syndrome, on psychological health in non-severe cases are limited. We aimed to evaluate the prevalence and associated risk factors of psychological symptoms, and quality-of-life in three groups of outpatients, hospitalized and intensive care patients.
    Methods: A total 276 patients, previously confirmed with SARS-CoV-2 infection, attending the COVID-19 follow-up outpatient clinic from December 2020 to July 2021 were interviewed face-to-face. In this cross-sectional, retrospective study, all participants were asked our self-designed demographic and screening questions to assess their psychological symptoms and administered the WHQOOL-BREF survey to evaluate quality of life.
    Results: In screening questions, major depressive disorder symptoms were detected at a rate of 20.3%, generalized anxiety disorder symptoms at a rate of 16.7%, panic attack symptoms at a rate of 10.9%, post-traumatic stress disorder symptoms at a rate of 28.6% and obsessive-compulsive disorder symptoms at a rate of 18.1%. The outpatient group with COVID-19 infection had a higher risk of developing psychological symptoms and decreased quality of life.
    Conclusion: COVID-19 infection was found to have a considerable psychological impact on those treated as outpatients despite the less severe course of their illness.
    MeSH term(s) Humans ; COVID-19/psychology ; COVID-19/epidemiology ; Cross-Sectional Studies ; Quality of Life ; Male ; Female ; Risk Factors ; Middle Aged ; Adult ; Prevalence ; Survivors/psychology ; Retrospective Studies ; Aged
    Language English
    Publishing date 2023-09-28
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 1381116-2
    ISSN 1440-172X ; 1322-7114
    ISSN (online) 1440-172X
    ISSN 1322-7114
    DOI 10.1111/ijn.13202
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top